SinoGreenTech Academic Portal
SR
Verified CAS / Academic Author2 Decoded Studies

Prof. SHI Ruicheng

School of Materials Science and Engineering, Tongji University

Co-Affiliations:Science China Materials

Research Publications & English Decoded Briefs

Showing 2 publications
SCIENCE CHINA Materials2026DOI: 10.1007/s40843-026-4213-x

Bioelectric Responsive Nanozymes for Catalytic Control of Lipid Peroxyl Radicals

Lipid peroxyl radicals (ROO·) are terminal propagating species in lipid peroxidation, driving oxidative damage in neurological disorders. Their prolonged lifetime and rapid diffusion within lipid membranes render them difficult to neutralize. Here, we report a bioelectric-responsive TEMPO-doped polydopamine (PDA@TEMPO) nanozyme that sustains catalytic interception of ROO· radicals under persistent oxidative stress. By coupling a PDA redox reservoir with TEMPO catalytic centers, the nanozyme establishes a self-regenerating radical-neutralization cycle via proton-coupled electron transfer (PCET). The π-conjugated framework facilitates charge migration and enables an electric-field-enhanced antioxidant response. In a seizure model, the nanozyme dynamically responds to bioelectric fluctuations, accelerating radical interception and alleviating oxidative stress in neural microenvironments. These findings establish bioelectric-coupled nanozymes as a general strategy for catalytic and sustained regulation of oxidative stress in neural microenvironments, providing a potential therapeutic approach for neurological disorders.

SCIENCE CHINA Materials2026DOI: 10.1007/s40843-025-4039-1

Inhibition of Residual Kynurenine Pathway Activity Boosts Antitumor Immune Responses

Immunosuppressive metabolites are major drivers of tumor immune suppression. Among these, kynurenine (Kyn) is produced through the catalysis of tryptophan (Trp) 2,3-dioxygenase (TDO) in hepatocellular carcinoma. However, TDO inhibition alone is often insufficient because residual pathway flux sustains the accumulation of the downstream immunosuppressive metabolite quinolinic acid (QA). Here, we propose a strategy to disrupt residual kynurenine pathway activity to enhance metabolism-driven tumor immunotherapy. We develop acid-responsive metal-organic complex nanoparticles (APAP@TDOi-Zn, ATZn) that integrate the TDO inhibitor (TDOi) and Zn2+, while encapsulating acetaminophen (APAP) to inhibit 3-hydroxyanthranilate 3,4-dioxygenase (HAAO), thereby limiting QA production and simultaneously suppressing the residual immunosuppressive metabolite. QA suppression limits M2 macrophage polarization, whereas Kyn inhibition and Zn2+ supplementation promote T cell proliferation and cytotoxicity. Consequently, ATZn rewires Trp-Kyn metabolism and augments antitumor immunotherapy. This work enhances the efficacy of metabolic checkpoint blockade and provides a strategy to overcome metabolism-driven immune resistance.